March 6, 2019

Putting Patient Uniqueness at the heart of Innovation

Abstract:

Technology Presentation made on March 2019 at the Patient Partnering in Clinical Development Conference, Berlin, Germany.

Access to innovative therapies remains an issue. In certain diseases, the magnitude and variability of individuals’ placebo response (IPR) can confound detection of positive results in clinical trials. Despite the best efforts and investments by  pharmaceutical industry stakeholders, patients are still waiting for optimal treatments. Tools4Patient is dedicated to accelerate patients’ access to novel therapies by optimizing clinical trial results interpretation thanks to IPR prediction. The complete package of patient information comprise usual demographics and disease data points but also patient’s unique  personality traits including outlook and expectations. Patient’s uniqueness needs to be characterized to optimize clinical trials results. Techniques like machine learning are critical. Our strong willingness to serve patient’s interest and assist the medical industry in getting safer and more efficacious therapies to market as soon as possible helped us to overcome the challenge of guiding innovation when using those mathematical approaches together with patient’s uniqueness. This strategic approach merge innovative thinking, patients’ interests and the company ones. We will present how we did it; how IPR can both serve patient’s interest and meet medical industry’s needs; as well as the challenges in transitioning from a pure R&D mindset to a commercial company. 

Type:
Technology Presentation
Authors:
Dominique Demolle, PhD; Stephanie Alvarez
Date:
March 1, 2019
Conference:
Patient Partnering in Clinical Development Conference
File:
Senior Public Relation and Marketing Associate

Related Posts

Publication

Correcting For The Individual Patient Regression To The Mean Effect

Often, the primary endpoint of RCTs is defined as a change from baseline of a continuous outcome. In…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Guillaume Bernard, PhD; Alvaro Pereira, PhD
Conference: American Society for Clinical Pharmacology and Therapeutics
Read More
Publication

Do Environmental Parameters Influence The Prediction Of The Placebo Response?

This proof-of-concept study on peripheral neuropathic pain patients investigates the potential influence of the investigator on the placebo…

Read More
Publication

Bayesian Modeling Of The Placebo Response In Neuropathic Pain

In analgesia randomized clinical trials (RCTs), the magnitude and the variability of the placebo response have a negative…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Alvaro Pereira, PhD; Frederic Clermont, PhD; Chantal Gossuin; Dominique Demolle, PhD
Conference: Promoting Statistical Insight Conference
Read More